Publication
Dual-mode lateral flow immunoassay based on gold nanoparticle-fluorescent microsphere nanocomposites for sensitive CA-125 detection in ovarian cancer screening.
Jiahui Wang, Junhong Li, Rurui Zhou, Ying Han, Chuan Fan, Haidong Li, Meng Tian, Congcong Mi, Guodong Liu
Analytica chimica actaOct 1, 2026PMID 42508911doi:10.1016/j.aca.2026.345814 Journal ArticleResearch Support, Non-U.S. Gov'tpubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Ovarian cancer remains a highly lethal malignancy, primarily due to the lack of rapid and reliable early screening tools. Cancer antigen 125 (CA-125) is a key serum biomarker, but conventional immunoassays are either too complex for point-of-care use or lack sufficient sensitivity.…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.